Skip to search formSkip to main contentSkip to account menu

A 145

Known as: A-145 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
International Travel and Sexually Transmitted Disease
7. Sahm DF, Thornsberry C, Jones ME, Blosser R, Critchley IA, Evangelista AT, Karlowsky JA. Antimicrobial susceptibility of… 
2018
2018
TCTAP A-145 Contrast Induced Nephropathy in Very Elderly Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
2004
2004
Bispectral Index (BIS) and Entropy monitoring differ in classification of depth of anaesthesia: A-145
2000
2000
Room 309, 10/18/2000 9: 00 AM - 10: 30 AM (PD) A Closer Look at Volatile Anesthetic Interaction with Ion Channel: One Femtosecond a Time A-145
1994
1994
A-145 搬送波周波数偏差を伴うM-ary/SS信号の受信に関する一検討(A-5. スペクトル拡散,一般講演)
1988
1988
Antitumor activity, mitogenicity, and lethal toxicity of chemically synthesized monosaccharide analogs of lipid A.
Antitumor activity of three derivatives of chemically synthesized diacyloxyacylglucosamine-4-phosphate (acyl-GlcN-4P) linked 3… 
1979
1979
[The difference of drug sensitivity of tumor cells on N-ethyloxycarbonylaminomethyl-L-isoleucine (A-145 (author's transl)].
N-Ethyloxycarbonylaminomehyl-L-isoleucine (A-145), a novel antitumor amino acid derivative, is an anti-tumor agent effect in… 
1975
1975
Antitumor activity of amino acid derivatives in the primary screening.
Approximately 350 amino acid derivatives were synthesized and tested for antitumor activity in four tumor systems. The effect on… 
1975
1975
Antitumor activity of selected amino acid derivatives against various tumor systems.
We have previously reported that from 350 amino acid (A-A) derivatives five were selected after the primary in vivo and in vitro… 
1975
1975
A-145 胎児内胎児と後腹膜奇形腫の検討
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)